Difficulty: Medium
Average Score: 83%
Practice
Half-life of OKT-3 is:
Correct answer
A
Rationale
The correct answer is A) 18-24 hours.
OKT-3 is a monoclonal antibody used in the treatment of acute transplant rejection. Its half-life refers to the time it takes for the concentration of the drug in the bloodstream to reduce by half.
Option B) 25-35 minutes is incorrect because this short half-life would not be practical for a therapeutic monoclonal antibody like OKT-3.
Option C) 4-16 hours is incorrect because it does not fall within the specified range for OKT-3's half-life.
Option D) 21 days is incorrect as this is an excessively long half-life for a drug like OKT-3 which is typically administered for acute conditions.
Understanding the half-life of drugs is crucial in pharmacology as it impacts dosing frequency, duration of action, and potential drug interactions. In the context of safety pharmacology across the lifespan, knowledge of drug kinetics is essential to ensure safe and effective medication use in patients of all ages.
OKT-3 is a monoclonal antibody used in the treatment of acute transplant rejection. Its half-life refers to the time it takes for the concentration of the drug in the bloodstream to reduce by half.
Option B) 25-35 minutes is incorrect because this short half-life would not be practical for a therapeutic monoclonal antibody like OKT-3.
Option C) 4-16 hours is incorrect because it does not fall within the specified range for OKT-3's half-life.
Option D) 21 days is incorrect as this is an excessively long half-life for a drug like OKT-3 which is typically administered for acute conditions.
Understanding the half-life of drugs is crucial in pharmacology as it impacts dosing frequency, duration of action, and potential drug interactions. In the context of safety pharmacology across the lifespan, knowledge of drug kinetics is essential to ensure safe and effective medication use in patients of all ages.